ALPHA-(4-METHYLTHIO-1-PHENYLPYRAZOLO-[3,4-D]-PYRIMIDIN-6-YLTHIO)-N-ETHYL-PROPANAMIDE
Compound with spectra: 1 NMR
![ALPHA-(4-METHYLTHIO-1-PHENYLPYRAZOLO-[3,4-D]-PYRIMIDIN-6-YLTHIO)-N-ETHYL-PROPANAMIDE](/api/compound/2AkuEeVk2Bf.png?ph=true&h=300&w=458 "ALPHA-(4-METHYLTHIO-1-PHENYLPYRAZOLO-[3,4-D]-PYRIMIDIN-6-YLTHIO)-N-ETHYL-PROPANAMIDE")
| SpectraBase Compound ID | 2AkuEeVk2Bf |
|---|---|
| InChI | InChI=1S/C17H19N5OS2/c1-4-18-15(23)11(2)25-17-20-14-13(16(21-17)24-3)10-19-22(14)12-8-6-5-7-9-12/h5-11H,4H2,1-3H3,(H,18,23) |
| InChIKey | ZMEKXRKHLRBQGV-UHFFFAOYSA-N |
| Mol Weight | 373.49 g/mol |
| Molecular Formula | C17H19N5OS2 |
| Exact Mass | 373.103103 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
ALPHA-(4-METHYLTHIO-1-PHENYLPYRAZOLO-[3,4-D]-PYRIMIDIN-6-YLTHIO)-N-PROPYL-PROPANAMIDE
ALPHA-(4-METHYLTHIO-1-PHENYLPYRAZOLO-[3,4-D]-PYRIMIDIN-6-YLTHIO)-PROPIONAMIDE
N-(4-chloro-2-methoxy-5-methylphenyl)-2-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)sulfanyl]acetamide
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)sulfanyl]acetamide
N-(4-chloro-2-methoxy-5-methylphenyl)-2-{[1-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]sulfanyl}acetamide
N-[1,1'-biphenyl]-2-yl-2-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)sulfanyl]acetamide
N-[2-chloro-5-(trifluoromethyl)phenyl]-2-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)sulfanyl]acetamide
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-{[1-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]sulfanyl}acetamide
N-[5-(acetylamino)-2-methoxyphenyl]-2-{[1-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]sulfanyl}acetamide
N-(1,3-benzodioxol-5-yl)-2-{[1-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]sulfanyl}acetamide
| Title | Journal or Book | Year |
|---|---|---|
| 1-Phenylpyrazolo[3,4- d ]pyrimidines; structure–activity relationships for C6 substituents at A 1 and A 2A adenosine receptors | Bioorganic & Medicinal Chemistry | 2000 |